Oncological Care

Ectoin® Mouth Wash

Concomitant therapy for cancer patients undergoing chemo- or radiotherapy


Concomitant therapy for cancer patients undergoing chemo- or radiotherapy.

  • Supports reduction of inflammation of oral mucous membranes (oral mucositis or stomatitis).
  • Helps to reduce the incidence of inflamed oral mucosa.
  • Alleviates and prevents symptoms such as sore mouth, redness and burning of the oral mucosa.
  • Helps to relieve pain in the mouth and therefore eases eating, drinking, and talking.
  • Moistens dry mouth and prevents from further dehydration.


Single-Doses: Ectoin®, Hydroxyethyl Cellulose, Phosphate Buffer, Xylitol, Water.

Suitable for

Infants, children, adolescents and adults.

Dosage Forms

Single-Doses: 10, 20 or 30 single-dose ampoules with 5 ml solution (preservative-free)

 Study Overview

Dao et al., 2018

  • 80 % of chemotherapy-patients with mucositis using Ectoin® Mouth Wash were entirely symptom-free after 3 weeks of treatment.
  • Efficacy and tolerability of Ectoin® Mouth Wash is significantly superior compared to standard treatment Caphosol®.
  • 100 % of chemotherapy-patients using the product preventively would recommend it to other patients.

Status (EU): Medical Device Class IIa (under approval)